Right heart dysfunction in acute pulmonary embolism: can echocardiography help predict risk

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study uses transthoracic echocardiography to assess right ventricular function in patients with acute pulmonary embolism. The goal is to determine whether measures of RV dysfunction provide prognostic information and aid in risk stratification. Data are collected from adults with confirmed PE who had an echocardiographic assessment, focusing on the relationship between RV findings and outcomes. The lead site is Sohag University Hospital, with no listed collaborators. The study design is observational and does not involve an interventional treatment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients aged 18 years and older.
* Patients with a confirmed diagnosis of acute pulmonary embolism.
* Patients who underwent transthoracic echocardiographic assessment for right ventricular dysfunction.

Exclusion Criteria:

* Patients younger than 18 years.
* Patients with incomplete clinical data.
* Patients who did not undergo transthoracic echocardiography.

Where it's running

• Sohag University hospital
  Sohag, Egypt Recruiting
• Sohag University hospital
  Sohag, Egypt Not yet recruiting

Study contacts

• Study coordinator: Safiya Khalaf Abdallah, Assistant lecturer
• Email: olaamer2026@gmail.com
• Phone: 0201090720819

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• TRiP-cast score test in adults with acute lower-limb injuries requiring immobilization

  This study tests whether the TRiP(cast) score can predict risk of blood clots in adults with acute lower-limb injuries treated as outpatients.

  Recruiting University of Monastir · Monastir · NCT07863115

• Prognostic value of the 2026 AHA/ACC PE classification in ED patients with acute PE

  This study tests whether the 2026 AHA/ACC five-category PE classification helps predict 30-day major adverse pulmonary embolism events in adults with acute PE presenting to the ED.

  Recruiting Marmara University Pendik Training and Research Hospital · Istanbul · NCT07805616

• Aspiration thrombectomy with the Symphony or Prodigy devices

  This project will try the Symphony and Prodigy aspiration thrombectomy devices to remove arterial, venous, or pulmonary blood clots in adults.

  Recruiting at 13 sites Imperative Care, Inc. · Huntsville, Alabama and 12 other locations · NCT07350499

• PERC and YEARS approaches for diagnosing pulmonary embolism in the emergency department.

  This project will test whether using the PERC score and the YEARS algorithm helps emergency doctors decide which adults need D-dimer blood tests or chest CT scans to diagnose pulmonary embolism.

  Recruiting University Hospital, Strasbourg, France · Strasbourg · NCT07313501

• Reperfusion options for acute pulmonary embolism

  This project will try catheter-directed interventions or systemic thrombolysis in adults with acute pulmonary embolism to see which approach leads to better outcomes.

  Recruiting at 12 sites Sahlgrenska University Hospital · Aarhus and 12 other locations · NCT07003646

• Evaluating anticoagulation duration for pulmonary embolism in ICU patients

  This study is testing how long ICU patients with serious pulmonary embolism should be treated with blood thinners to see how well it helps them recover.

  Recruiting University Hospital, Strasbourg, France · Strasbourg · NCT06912009

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.